FindTrial
Sign In

Finding out of most suitable option for the parameters of Ayurvedic Eye Drops Procedure.

â??OPTIMIZATION OF ASHCHYOTANA KRIYAKALPA PROCEDURE AND DEVELOPMENT OF STANDARD MANUFACTURING PROCEDURE (SMP) OF PUNARNAVADI EYE DROPS WITH THEIR CLINICAL EVALUATION IN ABHISHYANDA (CONJUNCTIVITIS)â??.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004214
Enrollment
100
Registered
2013-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with acquired Conjunctivitis

Interventions

Intervention1: Punarnavadi Eye Drops: Dose as developed through optimisaton, twice daily for 15 days Intervention2: Ofloxacin [OFLOX] Eye Drops: Day 1-2: Instill 1-2 drops in the affected eye(s) every

Sponsors

IPGT AND RA GAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria of Patients: Patients presenting with classical signs and symptoms of Abhishyanda (conjunctivitis â?? acute, subacute and chronic) e.g. ï?§ Discomfort, ï?§ Foreign body sensation, ï?§ Pain, ï?§ eyelid swelling, ï?§ Feeling of heat at lid margins, ï?§ Conjunctival congestion, ï?§ Chemosis, ï?§ Discharges, ï?§ Pre-auricular lymph node enlargement, ï?§ Matting of cilia, ï?§ Crusting of lids etc. Age limit of patients will be between ten to 60 years.

Exclusion criteria

Exclusion criteria: Exclusion criteria of Patients: 1. Patient not willing for registration. 2. Complicated conjunctivitis e.g. with glaucoma, uveitis, corneal ulcer, panophthalmitis / enophthalmitis, dacryocystitis, episcleritis, scleritis, dry eye etc. 3. Specific conjunctivitis (Tuberculous, lepromatous conjunctivitis etc.) 4. Non-specific systemic infections. 5. Patients of ocular trauma. 6. Uncontrolled diabetes mellitus. 7. Age limit of patients less than ten and greater than 60 years.

Design outcomes

Primary

MeasureTime frame
Finding out of optimum levels of Aschyotana Kriyakalpa Procedure Application. Timepoint: upto present study—

Secondary

MeasureTime frame
development of Standard Manufacturing Procedure (SMP)of Punarnavadi Eye Drops. Clinical Evaluaion of Punarnavadi Eye Drops on Conjunctivitis.Timepoint: upto present study—

Countries

India

Contacts

Public ContactDr K S Dhiman

IPGT AND RA GAU JAMNAGAR

dr_ks_dhiman@yahoo.co.in9723821965

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026